|
RPP30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.470080E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.297650E-01 |
| Normal-vs-Stage2 |
7.472100E-02 |
| Normal-vs-Stage3 |
3.489400E-01 |
| Normal-vs-Stage4 |
2.045500E-02 |
| Stage1-vs-Stage2 |
4.787000E-01 |
| Stage1-vs-Stage3 |
9.914400E-01 |
| Stage1-vs-Stage4 |
3.706000E-01 |
| Stage2-vs-Stage3 |
5.148000E-01 |
| Stage2-vs-Stage4 |
6.804400E-01 |
| Stage3-vs-Stage4 |
3.767800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.491900E-02 |
| Normal-vs-AfricanAmerican |
1.980380E-02 |
| Normal-vs-Asian |
3.469400E-01 |
| Caucasian-vs-AfricanAmerican |
4.389200E-01 |
| Caucasian-vs-Asian |
4.811400E-01 |
| AfricanAmerican-vs-Asian |
6.875800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.847650E-01 |
| Normal-vs-Female |
2.774500E-04 |
| Male-vs-Female |
1.738650E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.352810E-01 |
| Normal-vs-Extreme_Weight |
2.023400E-01 |
| Normal-vs-Obese |
1.651590E-02 |
| Normal-vs-Extreme_Obese |
8.875800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.551600E-01 |
| Normal_Weight-vs-Obese |
4.842200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.542400E-01 |
| Extreme_Weight-vs-Obese |
1.897430E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.514800E-01 |
| Obese-vs-Extreme_Obese |
1.958580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.572280E-02 |
| Normal-vs-Age(41-60Yrs) |
2.701500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.429200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.744000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.132400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.571700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.192450E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.714400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.542500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.478650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.696700E-03 |
| Normal-VS-Type2 PRCC |
3.705600E-01 |
| Normal-VS-KIRP CIMP |
3.959600E-02 |
| Normal-VS-Unclassified PRCC |
1.798780E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.809420E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.753350E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.579600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.242700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.079700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.131000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.274600E-01 |
| Normal-vs-N1 |
4.936000E-03 |
| Normal-vs-N2 |
8.389800E-01 |
| N0-vs-N1 |
1.044070E-02 |
| N0-vs-N2 |
7.961400E-01 |
| N1-vs-N2 |
3.929600E-01 |
|
|
